Clinical Trial Update: Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY) [Phase 2]

View source ↗

Summary

ABX-002 is being studied as an adjunctive treatment for adults with major depressive disorder in the AMPLIFY trial. The Phase 2 study is currently recruiting an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ABX-002

Snippet

Sponsor: Autobahn Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING